Medicina
Departament
Medical University of Silesia
Katowice, PoloniaPublicacions en col·laboració amb investigadors/es de Medical University of Silesia (14)
2019
-
Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: Twoyear follow-up of the SYNTAX II study
EuroIntervention, Vol. 15, Núm. 3, pp. E244-A252
-
Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: A European Scleroderma Trials and Research (EUSTAR) analysis
Annals of the Rheumatic Diseases, Vol. 78, Núm. 9, pp. 1242-1248
-
Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the european scleroderma trials and research (eustar) cohort
Annals of the Rheumatic Diseases, Vol. 78, Núm. 5, pp. 648-656
2018
-
Effect of hydrolyzed infant formula vs conventional formula on risk of type 1 diabetes the TRIGR randomized clinical trial
JAMA - Journal of the American Medical Association, Vol. 319, Núm. 1, pp. 38-48
2017
-
Global position paper on cardiovascular regenerative medicine
European Heart Journal
-
Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation
Bone Marrow Transplantation, Vol. 52, Núm. 3, pp. 372-380
-
The consensus of the Task Force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for the treatment of acute myocardial infarction and heart failure: Update 2016
European Heart Journal, Vol. 38, Núm. 39, pp. 2930-2935
-
The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: rationale and design of the BAMI trial
European Journal of Heart Failure, Vol. 19, Núm. 11, pp. 1545-1550
2016
2015
2012
-
Acute coronary syndromes: Considerations for improved acceptance and implementation of management guidelines
Expert Review of Cardiovascular Therapy, Vol. 10, Núm. 4, pp. 489-503
2011
-
The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents: A substudy of the RESOLUTE all comers trial (a randomized comparison of a zotarolimus-eluting stent with an everolimus-eluting stent for percutaneous coronary intervention)
Journal of the American College of Cardiology, Vol. 57, Núm. 22, pp. 2221-2232
2010
-
Comparison of zotarolimus-eluting and everolimus-eluting coronary stents
New England Journal of Medicine, Vol. 363, Núm. 2, pp. 136-146
2008
-
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
The Lancet, Vol. 372, Núm. 9641, pp. 807-816